Early detection methods for stomach cancer
Pro Research Analysisby 
Searched over 200M research papers
Overview of Early Detection Methods for Stomach (Gastric) Cancer
Early detection of stomach cancer is critical for improving survival rates, as most cases are diagnosed at advanced stages when treatment options are limited and outcomes are poor 234. Multiple methods—ranging from traditional endoscopy to advanced molecular and imaging techniques—are being developed and refined to identify gastric cancer at its earliest, most treatable stages 123.
Endoscopic Screening: Gold Standard and Innovations
Endoscopy with biopsy remains the gold standard for early detection of gastric cancer due to its ability to directly visualize and sample suspicious lesions 1238. Advanced endoscopic technologies, such as high-resolution imaging, chromoendoscopy, confocal laser endomicroscopy, and artificial intelligence-assisted systems, are improving the accuracy and sensitivity of lesion detection 2358. However, endoscopy is invasive, costly, and not suitable for mass screening in low-risk populations 128.
Second-generation narrow band imaging (2G-NBI) and white light imaging (WLI) are two endoscopic techniques compared for early gastric cancer detection. While 2G-NBI showed a slightly higher positive predictive value, it did not significantly increase detection rates over WLI, highlighting the need for further improvements in endoscopic sensitivity .
Non-Invasive and Minimally Invasive Biomarker-Based Methods
Liquid Biopsy and Molecular Biomarkers
Non-invasive liquid biopsy methods are emerging as promising tools for early gastric cancer detection. These approaches analyze biomarkers in blood, saliva, urine, stool, and gastric juice, including circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), microRNAs (miRNAs), long noncoding RNAs, and exosomes 1234+3 MORE. Multi-dimensional cfDNA analysis using whole-genome sequencing has demonstrated high sensitivity and specificity for distinguishing early-stage gastric cancer from non-cancerous conditions, even outperforming conventional gastroscopy in simulated large-scale screenings .
MicroRNAs, in particular, are stable and easily extracted from various body fluids, making them attractive candidates for non-invasive early detection, though they are still being validated for clinical use 489.
Serum and Metabolic Biomarkers
Traditional serum biomarkers such as CEA, CA19-9, and CA72-4 are widely used but lack sufficient sensitivity and specificity for early-stage detection 239. Newer metabolic and peptide biomarkers, including pepsinogen and gastrin-17, are being explored for their potential in large-scale, cost-effective screening, especially in high-risk populations 13.
Imaging-Based Screening Approaches
Imaging techniques such as upper gastrointestinal barium meal, multidimensional spiral CT, MRI, and ultrasonography are used for screening, but their effectiveness for early-stage detection is limited compared to endoscopy . Recent research into ultrasound full-waveform inversion (FWI) suggests this advanced imaging method could provide non-invasive, high-resolution images of stomach tissues, potentially enabling early detection in broader populations .
Artificial Intelligence and Deep Learning in Early Detection
Artificial intelligence (AI) and deep learning, particularly convolutional neural networks (CNNs), are being applied to analyze endoscopic and histopathological images. These systems have shown high accuracy in identifying early-stage stomach cancer, offering the potential to support clinicians and reduce diagnostic errors 58.
Future Directions and Integration of Methods
While endoscopy remains the most reliable method for early detection, integrating non-invasive biomarker assays, advanced imaging, and AI-driven analysis can enhance screening effectiveness, especially in populations where mass endoscopic screening is not feasible 1234+4 MORE. Ongoing research is focused on validating these new technologies and optimizing their use based on patient risk profiles.
Conclusion
Early detection of stomach cancer relies on a combination of established and emerging methods. Endoscopy with biopsy is the current gold standard, but non-invasive liquid biopsy, molecular biomarkers, advanced imaging, and AI-assisted diagnostics are rapidly advancing. Combining these approaches, tailored to patient risk and resource availability, holds the greatest promise for improving early diagnosis and survival rates in gastric cancer 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
Global progress and future prospects of early gastric cancer screening
Early gastric cancer screening methods have advanced globally, with imaging, endoscopic, and serum biomarker screening methods being the most prevalent and effective in detecting the disease early.
Leveraging Deep Learning for Early Detection of Stomach Cancer: A Convolutional Neural Network Approach
Our CNN-based framework accurately recognizes early-stage stomach cancer in medical images, potentially improving treatment outcomes and patient survival rates.
Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging
Second-generation narrow band imaging did not increase early gastric cancer detection rate in high-risk patients compared to conventional white light imaging.
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
A multi-dimensional cell-free DNA-based liquid biopsy assay accurately detects early-stage gastric cancer from non-cancerous conditions, potentially providing population-wide benefits for early detection.
Early-stage stomach cancer detection using ultrasound full-waveform inversion: a numerical study
Ultrasound full-waveform inversion shows significant potential for early-stage stomach cancer detection, offering a non-invasive, efficient method for detecting the disease.
DOI